Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
15,000
Total Value
$305,330.78
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 5,000 | $2.48 | $12,400.00 | 30,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Aug 17, 2026 | Sale | 3,900 | $58.37 | $227,649.63 | 26,100 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Aug 17, 2026 | Sale | 1,100 | $59.35 | $65,281.15 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 111,268 | Direct | โ | View Details |